These cytotoxic cells then eliminate tumor cells directly using an arsenal of granule-relayed and receptor-mediated cell death machinery; properties that have made CD8+ T cells an attractive target for therapeutic cancer vaccination [1]. Here, CD8A is linked to cancer.